The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.

The vaccine space has been battered by strong headwinds in recent weeks, including high-level disruptions to FDA and CDC ...

BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...

Here are some key projects around the world that AP has confirmed have closed: 1. In Congo, aid group Action Against Hunger ...

A promising new strategy for antimalarial treatment? A recent study discovers a gene regulation inhibitor that selectively ...

Here are some of the 5,800 contracts the Trump administration formally canceled this week in a wave of terse emails.

Tanzania’s Ambassador to Cuba, Hamphrey Polepole, highlighted that the Tanzanian government has invested significant efforts ...

Can a drug that's used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have ...

Lema Tefera's voice broke as he described losing four children to malaria in just one month - deaths that could likely have ...

Hundreds of people have tested positive for malaria in northwest Congo as health officials try to understand what is behind ...

Lagos State Ministry of Health, Akin Abayomi, the State Commissioner for Health emphasised that the program is a crucial step ...

Ned Nwoko, founder of the Prince Ned Nwoko Foundation, has committed over $20 million towards malaria vaccine research and ...